UC San Diego researchers discover children with MS experience accelerated biological aging, revealing new insights into neurological disease progression and potential treatment strategies. #MultipleSclerosis #MedicalResearch
#multipleSclerosis
Mind in the mist: the interplay between fatigue, information processing and brain fog
https://www.tandfonline.com/doi/full/10.1080/21641846.2025.2513194
Image is from the latest Science for ME weekly update
@mecfs
#MyalgicEncephalomyelitis #ChronicFatigueSyndrome #MEcfs #CFS #PwME @longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#brainfog #MultipleSclerosis @multiplesclerosis
It's brightened up now, the sort of evening where I could hop on the bike and do a nice few km's out in the lanes. Trouble is I did an indoor bike session this morning when it was dreadful weather, so I used up my activity budget for the day already.
#cycling #multiplesclerosis
“Rest recharges my energy”; experiences and perceptions of rest in adults with long-term conditions and fatigue in rehabilitation: a qualitative study
https://www.tandfonline.com/doi/full/10.1080/09638288.2025.2512587
"Lived-experience participants noted physical symptoms, while HCPs highlighted “all-or-nothing” thinking as a significant barrier."
#longcovid @longcovid #fatigue #chronicfatigue #fibromyalgia @fibromyalgia #multiplesclerosis @multiplesclerosis #arthritis #Sjogren #Sjögrens
So, I’m not disabled enough to take part in a trial aimed at slowing disease progression. Mildly frustrating, but be grateful for what you have, I reckon.
🧠 Can brain volume measurements forecast the course of multiple sclerosis?
🔗 Assessing the role of volumetric brain information in multiple sclerosis progression. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.05.003
📚 CSBJ: https://www.csbj.org/
#Neuroimaging #MultipleSclerosis #MachineLearning #MRI #PrecisionMedicine #BrainHealth #DBM #BrainMRI #DeepLearning #MSresearch #Neuroscience #AIinHealthcare #Biostatistics #MSprognosis
Activation of Kir4.1 Channels by 2‐D08 Promotes Myelin Repair in Multiple Sclerosis
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502282-24-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-503678-18-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502505-15-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (X-ACKT)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502286-16-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson’s Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-501783-18-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502000-73-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Das nützliche mit dem angenehmen verbinden: Übungen zur Koordination und Feinmothorik am Samstag 🥸😂😃
Märklin 3443 - DR BR 243
Das vermeintliche Schnäppchen 🥸 mit neuen Pantographen. Sie bekommt noch einen HLA und Digitaldecoder…
#märklin #maerklin #modellbahn
#modelleisenbahn #teppichbahn #parkettbahn #bodenbahn
#EinBisschenRandomModellbahn
#ms #multiplesclerosis #multiplesklerose
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07008378?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
What are our #WhiteheadInstitute scientists up to? In the first #ScienceIn60, @xochitl-luna.bsky.social breaks down her fascinating work on microglia, the brain's immune cells, and their role in #MS. Don't miss it!
#MultipleSclerosis #ResearchSky #AcademicSky
RE: https://bsky.app/profile/did:plc:376brirdwae4fayb4sd3bzdy/post/3lqv4diephs2x
Effect of Bobath Therapy on Balance Alterations in Patients With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07006259?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07006805?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Prolonged nicotine exposure, via electronic cigarette, selectively increases Bdnf/TrkB transcription, dynorphin peptide levels and OLIG2 in male rat VTA
HMGB1 Mediates Microglia-Astrocyte/Neuron Crosstalk and Pyroptosis by the TLR4/NF-kappaB Pathway in Multiple Sclerosis
Client Info
Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst